Featured Research

from universities, journals, and other organizations

"Safer Cigarette" Not So Safe

Date:
November 5, 1998
Source:
Roswell Park Cancer Institute
Summary:
There is no such thing as a "safe" cigarette, concludes Roswell Park Cancer Institute (RPCI) investigators, whose comprehensive analysis of one "safer cigarette" appears in today's issue of Cancer Epidemiology, Biomarkers & Prevention.

BUFFALO, NY - There is no such thing as a "safe" cigarette, concludes Roswell Park Cancer Institute (RPCI) investigators, whose comprehensive analysis of one "safer cigarette" appears in today's issue of Cancer Epidemiology, Biomarkers & Prevention.

In studies of Eclipse, a new nicotine-delivery device produced and test-marketed by R. J. Reynolds Tobacco Company, John L. Pauly, PhD, of the Department of Immunology, and his RPCI colleagues discovered that the "cigarettes" were contaminated with glass fibers, fragments and particles, that, when inhaled and/or ingested, may pose an additional health risk to users.

The researchers observed glass fibers on and within all parts of Eclipse, including its tip, wrapping and tipping papers, and in pack residue. In one study, they discovered that up to 95% of the Eclipse filters were contaminated with between five and 55 glass fibers. "Glass pollution of the filter of Eclipse was widespread, collective and continuous," according to Pauly. "In contrast, glass fibers were never observed on the filters of conventional United States cigarettes used as controls."

The researchers found an average of 7,548 thin and fragile glass fibers as well as numerous fiber fracture items (particles, fragments, bits, chips, flakes, specks, dust) in pack residue.

The culprit, say the researchers, appears to be the high-speed, multiple-step manufacturing process used to make Eclipse. However, regardless of what produces the thin, glass fibers, "our studies document glass fiber contamination of the filter and substantiate with reasonable certainty that glass fibers would be inhaled and/or ingested when Eclipse is smoked as intended," Pauly maintains.

The association of fibrous glass and cancer has been addressed by other investigators from the National Institute of Environmental Health Sciences, Duke University Medical Center and OSHA. These examiners analyzed animal and human data and declared "that fibrous glass materials are carcinogenic..." and concluded "...that on a fiber-per-fiber basis, glass fibers may be as potent or even more potent than asbestos."

Nicotine-delivery devices -- gum, patches, etc. - have been developed by the pharmaceutical industry over the past 10 years to wean smokers from their addiction to nicotine, while protecting them from the more than 3,000 dangerous chemicals found in cigarette smoke, and reducing environmental tobacco smoke. These products have been tested extensively, and their safety and effectiveness have been demonstrated to the Food & Drug Administration before introduction. In fact, at first, these products were available only through a physician's prescription.

To keep pace, R. J. Reynolds began to market test Premier, one of several smoking devices that resembled conventional cigarettes but, unlike conventional cigarettes, was designed to heat, rather than burn, tobacco. "The purpose of these 'heat but not burn prototypes' was to simplify the chemical composition and reduce the biological activity of the mainstream and sidestream smoke and to significantly reduce environmental tobacco smoke, while delivering nicotine to its users," according to Pauly. Premier performed poorly in the marketplace and was soon replaced by Eclipse.

In the Eclipse design, the chemical changes in tobacco are reduced by a carbon fuel rod that, when ignited, heats reconstituted tobacco to generate a low-smoke, nicotine-containing aerosol that has a tobacco flavor. The carbon rod at the end of the "cigarette" is insulated and bound with two wrapping mats of glass fibers. These mats secure the position of the carbon fuel rod, insulate the burning rod and direct heat from the rod to the adjacent tobacco column. "The breakdown of these glass fiber mats is the major problem in this nicotine-delivery device that has a cigarette-like appearance," explains Pauly.

Dr. Pauly and his colleagues conclude that, "Eclipse is the paradigm of the health danger that may be imposed by technically complex tobacco articles and nicotine-delivery devices promoted by an unregulated industry to smokers worldwide, many of whom are addicted to nicotine and who seek a less hazardous cigarette."

Roswell Park Cancer Institute was founded in 1898, is the nation's first and one of its largest cancer research, treatment and education centers, and is the only National Cancer Institute-designated comprehensive cancer center in Western New York.


Story Source:

The above story is based on materials provided by Roswell Park Cancer Institute. Note: Materials may be edited for content and length.


Cite This Page:

Roswell Park Cancer Institute. ""Safer Cigarette" Not So Safe." ScienceDaily. ScienceDaily, 5 November 1998. <www.sciencedaily.com/releases/1998/11/981105065259.htm>.
Roswell Park Cancer Institute. (1998, November 5). "Safer Cigarette" Not So Safe. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/1998/11/981105065259.htm
Roswell Park Cancer Institute. ""Safer Cigarette" Not So Safe." ScienceDaily. www.sciencedaily.com/releases/1998/11/981105065259.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com
$23.6 Billion Awarded To Widow In Smoking Lawsuit

$23.6 Billion Awarded To Widow In Smoking Lawsuit

Newsy (July 20, 2014) Cynthia Robinson claims R.J. Reynolds Tobacco Company hid the health and addiction risks of its products, leading to the death of her husband in 1996. Video provided by Newsy
Powered by NewsLook.com
Tooth Plaque Provides Insight Into Diets Of Ancient People

Tooth Plaque Provides Insight Into Diets Of Ancient People

Newsy (July 19, 2014) Research on plaque from ancient teeth shows that our prehistoric ancestor's had a detailed understanding of plants long before developing agriculture. Video provided by Newsy
Powered by NewsLook.com
Contaminated Water Kills 3 Babies in South African Town

Contaminated Water Kills 3 Babies in South African Town

AFP (July 18, 2014) Contaminated water in South Africa's northwestern town of Bloemhof kills three babies and hospitalises over 500 people. The incident highlights growing fears over water safety in South Africa. Duration: 02:22 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins